Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …

Background: The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in patients with COVID-19 requiring oxygen and/or ventilator …

Introduction After emerging the global pandemic of SARS-CoV2 some preliminary studies
demonstrated the efficacy of antiviral treatments. But shortly thereafter, inconsistencies in the …

Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …

Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

Aims Remdesivir is 1 of the repurposed drugs under investigation to treat patients with
COVID‐19. Clinicians and decision‐makers need a summary of the most recent evidence …

Objective This living systematic review aims to provide a timely, rigorous and continuously
updated summary of the evidence available on the role of remdesivir in the treatment of …

Abstract Background Coronavirus disease 2019 (COVID-19), caused by the novel
coronavirus SARS-CoV-2, has led to significant global mortality and morbidity. Until now, no …

BACKGROUND Remdesivir, an inhibitor of viral RNA-dependent RNA polymerases, has
been identified as a candidate for COVID-19 treatment. However, the therapeutic effect of …

This registration describes the protocol of the currently ongoing systematic review and meta-
analysis aiming to use individual patient data (IPD) from all available randomized clinical …